Switching from semaglutide (Wegovy, Ozempic) to tirzepatide (Zepbound, Mounjaro) — or vice versa — is becoming more common as patients and prescribers seek the best individual response. Here is how the prescription transfer works and what to expect.
Why Patients Switch
The most common reasons for switching include weight-loss plateaus on semaglutide (tirzepatide's dual GIP/GLP-1 mechanism may break plateaus), persistent side effects that are not resolving with dose adjustments, insurance coverage changes (one may be covered while the other is not), cost considerations (compounded pricing varies between the two), or provider recommendations based on emerging clinical data.
The Dose Conversion
There is no official FDA dose-equivalency chart between semaglutide and tirzepatide, because they are different molecules with different mechanisms. However, prescribers generally follow established conversion guidance:
| Current Semaglutide Dose | Typical Starting Tirzepatide Dose |
|---|---|
| 0.25–0.5 mg/week | 2.5 mg/week (standard start) |
| 1.0 mg/week | 2.5–5.0 mg/week |
| 1.7 mg/week | 5.0 mg/week |
| 2.4 mg/week | 5.0–7.5 mg/week |
Key Point
Most prescribers start tirzepatide at 2.5mg regardless of your current semaglutide dose, then titrate based on response. The conservative approach minimizes GI side effects during the transition. Your prescriber will customize the switch based on your tolerance and goals.
The Transition Process
Step 1: Discuss With Your Prescriber
Explain why you want to switch — plateau, side effects, cost, or other reasons. Your prescriber needs to understand the clinical rationale to make the right conversion decision.
Step 2: Timing the Switch
Most prescribers recommend waiting until your next scheduled injection day to make the switch. There is no washout period needed between semaglutide and tirzepatide — you can switch directly. However, some prescribers prefer a 1-week gap to let semaglutide levels decline slightly.
Step 3: Expect a New Titration
Even if you were on a high dose of semaglutide, tirzepatide titration typically starts at or near the beginning. This is because the dual GIP/GLP-1 mechanism can produce different side effect profiles, and your body needs to adjust to the new molecule.
Do not attempt to self-adjust doses when switching between semaglutide and tirzepatide. These are different medications with different pharmacokinetics. Always follow your prescriber's dosing instructions during the transition.
SHED From $297/mo · Comprehensive weight-loss program with GLP-1 prescriptions. Starts ~$297/mo; doses above 7.5mg may increase to $399/mo.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
Pricing note: doses above 7.5mg may increase to ~$399/mo. Confirm pricing during consultation.
Yucca Health $146/mo sema (6-mo) · Semaglutide from $146/mo or tirzepatide from $258/mo on 6-month plans. Free medical consultation.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
Bodybuilding.com Health From $199/mo · GLP-1 prescriptions paired with fitness and nutrition guidance. Backed by Bodybuilding.com's health platform.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
What to Expect After Switching
Patients who switch from semaglutide to tirzepatide commonly report renewed appetite suppression (if they had plateaued on semaglutide), different GI side-effect patterns (some find tirzepatide easier on the stomach; others experience new GI adjustment), and potentially faster weight loss in the initial months after switching.
Conversely, some patients switch from tirzepatide to semaglutide due to better insurance coverage for semaglutide or preference for the single-agonist mechanism. The clinical outcomes are individual — there is no universally "better" option.